The TCI was developed with LABVIEW® 6.1 National Instruments, Austin, USA software that enabled continuous and variable infusion of liquid sevoflurane at the AESPIRE-VIEW® GE-Healthcare, Madison, USA station, using the Harvard Apparatus 22 South Natick, USA infusion syringe.
UU., que permitió la infusión continua y variable del sevofluorano líquido en la estación Aespire-ViewGE-Healthcare, Madison, EE. UU., empleando la jeringa infusora Harvard Apparatus 22 South Natick, EE.